• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分泌李斯特菌溶素的重组牛分枝杆菌卡介苗突变株对结核病的疫苗效力增强。

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

作者信息

Grode Leander, Seiler Peter, Baumann Sven, Hess Jürgen, Brinkmann Volker, Nasser Eddine Ali, Mann Peggy, Goosmann Christian, Bandermann Silke, Smith Debbie, Bancroft Gregory J, Reyrat Jean-Marc, van Soolingen Dick, Raupach Bärbel, Kaufmann Stefan H E

机构信息

Max Planck Institute for Infection Biology, Berlin, Germany.

出版信息

J Clin Invest. 2005 Sep;115(9):2472-9. doi: 10.1172/JCI24617. Epub 2005 Aug 18.

DOI:10.1172/JCI24617
PMID:16110326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1187936/
Abstract

The tuberculosis vaccine Mycobacterium bovis bacille Calmette-Guérin (BCG) was equipped with the membrane-perforating listeriolysin (Hly) of Listeria monocytogenes, which was shown to improve protection against Mycobacterium tuberculosis. Following aerosol challenge, the Hly-secreting recombinant BCG (hly+ rBCG) vaccine was shown to protect significantly better against aerosol infection with M. tuberculosis than did the parental BCG strain. The isogenic, urease C-deficient hly+ rBCG (DeltaureC hly+ rBCG) vaccine, providing an intraphagosomal pH closer to the acidic pH optimum for Hly activity, exhibited still higher vaccine efficacy than parental BCG. DeltaureC hly+ rBCG also induced profound protection against a member of the M. tuberculosis Beijing/W genotype family while parental BCG failed to do so consistently. Hly not only promoted antigen translocation into the cytoplasm but also apoptosis of infected macrophages. We concluded that superior vaccine efficacy of DeltaureC hly+ rBCG as compared with parental BCG is primarily based on improved cross-priming, which causes enhanced T cell-mediated immunity.

摘要

结核疫苗牛分枝杆菌卡介苗(BCG)配备了单核细胞增生李斯特菌的膜穿孔溶菌酶(Hly),已证明其可增强对结核分枝杆菌的保护作用。经气溶胶攻击后,分泌Hly的重组卡介苗(hly+rBCG)疫苗对结核分枝杆菌气溶胶感染的保护作用明显优于亲本卡介苗菌株。同基因的、脲酶C缺陷的hly+rBCG(DeltaureC hly+rBCG)疫苗,其吞噬体内pH值更接近Hly活性的最佳酸性pH值,表现出比亲本卡介苗更高的疫苗效力。DeltaureC hly+rBCG还能对结核分枝杆菌北京/W基因型家族的一个成员产生深度保护,而亲本卡介苗则不能始终如此。Hly不仅促进抗原转运到细胞质中,还能诱导被感染巨噬细胞凋亡。我们得出结论,与亲本卡介苗相比,DeltaureC hly+rBCG具有更高的疫苗效力,主要是基于改善的交叉呈递,这导致T细胞介导的免疫增强。

相似文献

1
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.分泌李斯特菌溶素的重组牛分枝杆菌卡介苗突变株对结核病的疫苗效力增强。
J Clin Invest. 2005 Sep;115(9):2472-9. doi: 10.1172/JCI24617. Epub 2005 Aug 18.
2
Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.膳食中的吡哆醇可控制维生素B6营养缺陷型结核疫苗卡介苗ΔureC::hly Δpdx1在小鼠体内的功效。
mBio. 2014 Jun 3;5(3):e01262-14. doi: 10.1128/mBio.01262-14.
3
The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice.卡介苗ΔureC::hly 株共表达人白细胞介素-7 或 -18 增强小鼠的抗原特异性 T 细胞应答。
PLoS One. 2013 Nov 13;8(11):e78966. doi: 10.1371/journal.pone.0078966. eCollection 2013.
4
Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes.分泌单核细胞增生李斯特菌溶血素的牛分枝杆菌卡介苗菌株。
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5299-304. doi: 10.1073/pnas.95.9.5299.
5
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.从候选疫苗牛分枝杆菌卡介苗ΔureC::hly中删除nuoG可增强对结核病的保护作用。
mBio. 2016 May 24;7(3):e00679-16. doi: 10.1128/mBio.00679-16.
6
Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.分泌白细胞介素-15/抗原85B融合蛋白的重组卡介苗在提供抗结核分枝杆菌保护方面的疗效
J Infect Dis. 2008 May 1;197(9):1263-74. doi: 10.1086/586902.
7
Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.评估表达 Ag85A-ESAT-6 融合蛋白的重组牛分枝杆菌卡介苗的保护效力。
J Microbiol Immunol Infect. 2014 Feb;47(1):48-56. doi: 10.1016/j.jmii.2012.11.005. Epub 2013 Jan 26.
8
A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.一种表达多阶段抗原 Ag85B 和 HspX 的减毒活卡介苗疫苗可提供针对结核分枝杆菌感染的卓越保护。
Appl Microbiol Biotechnol. 2015 Dec;99(24):10587-95. doi: 10.1007/s00253-015-6962-x. Epub 2015 Sep 12.
9
Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.重组卡介苗 ΔureC hly+ 通过刺激 1 型和 17 型细胞因子反应的平衡组合,诱导优于亲本卡介苗的保护作用。
J Infect Dis. 2011 Nov 15;204(10):1573-84. doi: 10.1093/infdis/jir592. Epub 2011 Sep 20.
10
Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.分泌结核分枝杆菌抗原ESAT-6的重组牛分枝杆菌卡介苗菌株在小鼠中的表达及免疫原性
Chin Med J (Engl). 2007 Jul 20;120(14):1220-5.

引用本文的文献

1
Unleashing the power of the BCG vaccine in modulating viral immunity through heterologous protection: A scoping review.通过异源保护释放卡介苗疫苗在调节病毒免疫方面的潜力:一项范围综述。
Hum Vaccin Immunother. 2025 Dec;21(1):2521190. doi: 10.1080/21645515.2025.2521190. Epub 2025 Jul 3.
2
Recombinant BCG-Based HIV Vaccine: Failures and Promising Approaches for a Successful Vaccine Strategy.基于重组卡介苗的HIV疫苗:成功疫苗策略的失败与前景方法
Vaccines (Basel). 2025 Jun 3;13(6):606. doi: 10.3390/vaccines13060606.
3
A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models.临床结核病候选疫苗在小鼠模型中的疗效综述。
Front Immunol. 2025 May 29;16:1609136. doi: 10.3389/fimmu.2025.1609136. eCollection 2025.
4
Dendritic Cell Vaccine Harboring Inactivated Mycobacteria Induces Immune Protection Against Tuberculosis in Murine Models and is Well Tolerated in Humans.携带灭活分枝杆菌的树突状细胞疫苗在小鼠模型中诱导抗结核免疫保护,且在人体中耐受性良好。
Small Sci. 2024 Dec 18;5(2):2400355. doi: 10.1002/smsc.202400355. eCollection 2025 Feb.
5
Cross-District Transmission of Tuberculosis in a High-Mobility City in China: Implications for Regional Collaboration in Infectious Disease Control.中国一个高流动性城市的结核病跨区传播:对传染病防控区域协作的启示
Infect Drug Resist. 2025 Mar 19;18:1551-1560. doi: 10.2147/IDR.S516162. eCollection 2025.
6
BCG therapy in bladder cancer and its tumor microenvironment interactions.卡介苗治疗膀胱癌及其与肿瘤微环境的相互作用。
Clin Microbiol Rev. 2025 Jun 12;38(2):e0021224. doi: 10.1128/cmr.00212-24. Epub 2025 Mar 20.
7
Tuberculosis vaccines and therapeutic drug: challenges and future directions.结核病疫苗与治疗药物:挑战与未来方向
Mol Biomed. 2025 Jan 22;6(1):4. doi: 10.1186/s43556-024-00243-6.
8
An mRNA vaccine induces antimycobacterial immunity by activating DNA damage repair and autophagy.一种信使核糖核酸(mRNA)疫苗通过激活DNA损伤修复和自噬来诱导抗分枝杆菌免疫。
Mol Ther Nucleic Acids. 2024 Nov 26;36(1):102402. doi: 10.1016/j.omtn.2024.102402. eCollection 2025 Mar 11.
9
The danger theory of immunity revisited.重新审视免疫的危险理论。
Nat Rev Immunol. 2024 Dec;24(12):912-928. doi: 10.1038/s41577-024-01102-9. Epub 2024 Nov 7.
10
The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against .卡介苗疫苗、新一代抗……疫苗的优缺点
Clin Exp Vaccine Res. 2024 Jul;13(3):184-201. doi: 10.7774/cevr.2024.13.3.184. Epub 2024 Jul 31.

本文引用的文献

1
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.消除危险关联:预防艾滋病和结核病的疫苗接种策略
Nat Med. 2005 Apr;11(4 Suppl):S33-44. doi: 10.1038/nm1221.
2
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.表达85A抗原的重组改良安卡拉痘苗病毒可增强卡介苗启动的和自然获得的人体抗分枝杆菌免疫力。
Nat Med. 2004 Nov;10(11):1240-4. doi: 10.1038/nm1128. Epub 2004 Oct 24.
3
Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.分枝杆菌蛋白质组学在疫苗设计中的应用:牛分枝杆菌卡介苗初免-Rv3407 DNA加强免疫接种对结核病的保护作用增强
Infect Immun. 2004 Nov;72(11):6471-9. doi: 10.1128/IAI.72.11.6471-6479.2004.
4
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.一种抑制先天性免疫反应的高毒力结核菌株的糖脂。
Nature. 2004 Sep 2;431(7004):84-7. doi: 10.1038/nature02837.
5
Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis.单核细胞的差异性激活是结核分枝杆菌菌株特异性发病机制的基础。
Infect Immun. 2004 Sep;72(9):5511-4. doi: 10.1128/IAI.72.9.5511-5514.2004.
6
Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface.牛分枝杆菌卡介苗脲酶减弱主要组织相容性复合体II类分子向巨噬细胞表面的转运。
Infect Immun. 2004 Jul;72(7):4200-9. doi: 10.1128/IAI.72.7.4200-4209.2004.
7
Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.使用重组病毒和卡介苗进行异源初免-加强免疫接种在牛体内诱导的细胞免疫反应。
Immunology. 2004 Jul;112(3):461-70. doi: 10.1111/j.1365-2567.2004.01903.x.
8
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages.
J Antimicrob Chemother. 2004 May;53(5):863-6. doi: 10.1093/jac/dkh164. Epub 2004 Mar 31.
9
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.在HeLa细胞中选择性破坏溶酶体可触发由多种木瓜蛋白酶样溶酶体组织蛋白酶切割Bid介导的细胞凋亡。
J Biol Chem. 2004 Jan 30;279(5):3578-87. doi: 10.1074/jbc.M308347200. Epub 2003 Oct 27.
10
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.俄罗斯阿尔汉格尔斯克监狱结核分枝杆菌分离株的分子流行病学及耐药性:W-北京克隆家族占主导地位
Clin Infect Dis. 2003 Sep 1;37(5):665-72. doi: 10.1086/377205. Epub 2003 Aug 14.